Mefenorex

ALIMENTARY TRACT AND METABOLISM

Key facts

Mefenorex is a drug catalogued in DrugCentral. Recorded indications include Obesity.

• Indications: Obesity.
• ATC code: A08AA09 (Centrally acting antiobesity products).
• Molecular formula: C12H18ClN; molecular weight 211.73 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Obesity

ATC classification

ATC code	Therapeutic hierarchy
A08AA09	ALIMENTARY TRACT AND METABOLISM › ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS › ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS › Centrally acting antiobesity products

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mefenorex is on its molecule page.

• Molecular formula: C₁₂H₁₈ClN
• Molecular weight: 211.73 g/mol
• CAS number: 17243-57-1
• InChIKey: XXVROGAVTTXONC-UHFFFAOYSA-N
• PubChem CID: 21777

CC(CC1=CC=CC=C1)NCCCCl

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Mefenorex used for?

DrugCentral lists the following indications for Mefenorex: Obesity.

What is the chemical formula of Mefenorex?

Mefenorex has the molecular formula C12H18ClN and a molecular weight of 211.73 g/mol.

Sources

• DrugCentral drug card 1664 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2106838 — compound record and bioactivity
• PubChem CID 21777 — chemical identifiers
• DrugBank DB13852 — drug record
• FDA UNII K98M4N387W — substance identity

How this page is built: methodology · editorial policy & corrections.